119th Congress · House
HR. 679
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
committee
Introduced 2025-01-23•Latest 2025-01-23
Origin chamber
House
Cosponsors
17
Latest action
Referred to the House Committee on Energy and Commerce.
Subjects
AbortionDrug safety, medical device, and laboratory regulationDrug therapyHealthPrescription drugs
Key actions
- Introduced in House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
Bill text versions
Related bills
No related bills listed.